Abstract
We describe the application of genetic programming, an
evolutionary computing method, to predicting whether
small molecules will block the HERG cardiac potassium
channel. Models based on a molecular fragment-based
descriptor set achieve an accuracy of 85-90% in
predicting whether the IC50 of a 'blind' set of
compounds is <1 muM. Analysis of the models provides
a 'meta-SAR', which predicts a pharmacophore of two
hydrophobic features, one preferably aromatic and one
preferably nitrogen-containing, with a protonatable
nitrogen asymmetrically situated between them. Our
experience of the approach suggests that it is robust,
and requires limited scientist input to generate
valuable predictive results and structural
understanding of the target.
Users
Please
log in to take part in the discussion (add own reviews or comments).